| Financial Year |
March 31 2023 |
| Monetary Funds |
1,349,708,731.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,258,457,225.06 |
| Advances to Suppliers |
271,890,854.48 |
| Other Receivables |
72,713,925.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,826,131,412.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
411,698,049.98 |
| Total Current Assets |
8,387,157,706.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,610,016,570.19 |
| Under-construction Projects |
1,679,430,765.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
284,734,488.70 |
| R&D expenses |
-- |
| Goodwill |
12,080,957.41 |
| Long-Term Deferred and Prepaid Expenses |
99,241,786.81 |
| Deferred Income Tax Assets |
46,789,878.17 |
| Other Non-Current Assets |
53,588,701.92 |
| Sub-Total of Non-Current Assets |
5,807,803,718.87 |
| Total Assets |
14,194,961,425.66 |
| Short-Term Loans |
1,236,594,770.83 |
| Trading Financial liabilities |
37,166,514.46 |
| Notes Payable |
1,212,885,043.04 |
| Accounts Payable |
937,691,361.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
100,591,810.37 |
| Taxes Payable |
58,034,676.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
91,772,365.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
549,804,635.95 |
| Other Current Liabilities |
10,414,950.33 |
| Sub-Total of Current Liabilities |
5,333,149,565.21 |
| Long-term Loans |
2,348,867,552.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
68,446,405.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,091,997.00 |
| Deferred Income Tax Liabilities |
12,726,745.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,677,712,544.93 |
| Total Liabilities |
8,010,862,110.14 |
| Paid-In Capital(Or Share Stock) |
790,044,972.00 |
| Capital Surplus |
2,655,835,043.67 |
| Surplus Reserve |
133,392,521.69 |
| LESS:Treasury Stock |
14,258,218.20 |
| Undistributed Profits |
2,604,925,085.51 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,184,099,315.52 |
| Owner's Equity（Stockholder's Equity） |
6,184,099,315.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,194,961,425.66 |
